Chemours (CC) Consolidated Net Income (2014 - 2026)

Chemours' Consolidated Net Income history runs 13 years deep, the most recent figure standing at -$29.0 million for Q1 2026.

• On a quarterly basis, Consolidated Net Income fell 480.0% year-over-year to -$29.0 million in Q1 2026; TTM through Mar 2026 was -$308.0 million, a 2666.67% decrease from a year earlier, with the FY2025 full-year figure at -$460.0 million, down 121.15% from the prior year.
• Consolidated Net Income retreated to -$29.0 million in Q1 2026 per CC's latest filing, from $54.0 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $240.0 million in Q3 2022 and bottomed at -$379.0 million in Q2 2025.
• The 5-year median for Consolidated Net Income is $12.0 million (2023), against an average of $1.9 million.
• Biggest YoY gain for Consolidated Net Income was 590.91% in 2025; the steepest drop was 731.67% in 2025.
• Year by year, Consolidated Net Income stood at -$97.0 million in 2022, then advanced by 12.37% to -$85.0 million in 2023, then surged by 87.06% to -$11.0 million in 2024, then jumped by 590.91% to $54.0 million in 2025, then slumped by 153.7% to -$29.0 million in 2026.
• Per Business Quant, the three latest CC Consolidated Net Income figures stand at -$29.0 million (Q1 2026), $54.0 million (Q4 2025), and $46.0 million (Q3 2025).